-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LIS-1 in Kidney Transplant Rejection
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LIS-1 in Kidney Transplant Rejection Drug Details: LIS-1 (polyclonal antibodies) are under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XAB-5 in Bacterial Infections
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XAB-5 in Bacterial Infections Drug Details: XAB-5 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Hyaluronidase (Recombinant, Human) + Immune Globulin (Human)) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Hyaluronidase (Recombinant, Human) + Immune Globulin (Human)) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Drug Details:Human normal immunoglobulin...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Refractory Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Immune Globulin (Human) in Refractory Chronic Lymphocytic Leukemia (CLL) Drug Details: Human normal immunoglobulin (Octagam, ...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Immune Globulin (Human) in Chronic Lymphocytic Leukemia (CLL) Drug Details: Human normal immunoglobulin (Octagam, Gamten,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Relapsed Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Immune Globulin (Human) in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug Details: Human normal immunoglobulin (Octagam, ...
-
Product Insights
![]()
Seraing City – Gastronomia Mixed-Use Development – Wallonia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Seraing City - Gastronomia Mixed-Use Development - Wallonia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
![]()
SERAS Italy – Mungivacca to Noicattaro Metro Line Upgrade – Apulia
Equip yourself with the essential tools needed to make informed and profitable decisions with our SERAS Italy - Mungivacca to Noicattaro Metro Line Upgrade - Apulia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Luminus/ Nethys – Seraing Combined Cycle Power Plant 870 MW – Wallonia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Luminus/ Nethys - Seraing Combined Cycle Power Plant 870 MW - Wallonia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
![]()
Sera Prognostics Inc Pipeline Insight and Competitive Landscape, 2023
Sera Prognostics Inc (Sera Prognostics) is a biotechnology firm, specialized in providing diagnostic tests for predicting the risk of pregnancy complications such as premature birth and preeclampsia. It offers PreTRM, a proteomic predictor of premature birth risk for clinicians, mothers, and doctors to deliver personalized care plans and treatments for improving the newborn and maternal health. Sera Prognostics is headquartered in Salt Lake, Utah, the United States. GlobalData's Medical Devices company profile report, “Sera Prognostics Inc Pipeline Insight and Competitive...
-
Product Insights
![]()
Diabetes Assays Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Diabetes Assays Pipeline Market Report Overview Diabetes assays comprises of C-Peptide Assay, Glycated Hemoglobin (HbA1c) Lab Assay, Glycated Hemoglobin (HbA1c) Point of care (POC) Assay, Insulin Assay, and Fasting Glucose Assay. C-Peptide is a single chain polypeptide secreted by the pancreatic ß-cells in equimolar amounts to Insulin. Insulin is a metabolism regulating hormone secreted by ß-cells of the islets of Langerhans of the pancreas. Diabetes assays pipeline market research report provides comprehensive information about the diabetes assays pipeline products with...
-
Product Insights
New![]()
Seraing Combined Cycle Power Plant New
Seraing Combined Cycle Power Plant New is a thermal project located in Liege, Belgium. The project is owned and being developed by Luminus SA. The project is at the permitting stage. Empower your strategies with our Seraing Combined Cycle Power Plant New report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
![]()
Hematology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hematology Pipeline Market Report Overview Hematology tests evaluate numerous conditions involving blood and its components and the tests that generate results immediately and can be done in a limited resource setting. The hematology pipeline market research report provides comprehensive information about the hematology pipeline reconstruction with a comparative analysis of the reconstruction at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Immunohematology ·      Hematology Reagents ·      Hemostasis Calibrators and Controls ·      ...
-
Product Insights
New![]()
Seraing Combined Cycle Power Plant
Seraing Combined Cycle Power Plant is a thermal project located in Liege, Belgium. The project is owned by Electricite de France SA. The project came online in 1994. Empower your strategies with our Seraing Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Company Profile
![]()
John Cockerill Group – Company Profile
John Cockerill Group (John Cockerill), formerly CMI Group, designs and manufactures large-scale technological solutions. The company develops heat recovery steam generators, thermo-solar power plant boilers, industrial boilers, weapon systems, simulators, security, and safety technologies. It also offers reheating furnaces, pickling solutions, rolling mills, strip processing lines, automation and process control systems, heat, water and waste treatment solutions. John Cockerill provides welding, lifting, training, on-site machining, electricity, automation and instrumentation, spare parts management, installation maintenance, project management, and other related services....
Add to Basket -
Product Insights
![]()
Saudi Basic – Jubail Industrial City: Emergency Response Academy (SERA) – Eastern Province
Equip yourself with the essential tools needed to make informed and profitable decisions with our Saudi Basic - Jubail Industrial City: Emergency Response Academy (SERA) - Eastern Province report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Sector Analysis
![]()
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Report Overview Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. Â Influenza infection is normally self-limiting. Symptoms generally last for one to two weeks, but most people infected with influenza do not need or seek medical treatment. The Seasonal Influenza Therapeutics (SIT) marketed and pipeline drugs market research report provides a data-driven overview...
-
Product Insights
![]()
Net Present Value Model: Adrenalin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Adrenalin Drug Details Epinephrine (Adrenalin) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – XAB-5
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry XAB-5 Drug Details XAB-5 is under development for the treatment of multi drug resistant...
-
Product Insights
![]()
Net Present Value Model: Bivigam
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Bivigam Drug Details Human immunoglobulin (Bivigam...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.